Skip to content
Screener

PTC Therapeutics PTCT Business Segments — Occupancy Costs

Similar metrics at other companies

Clarivate logo
CLVTLife Sciences & Healthcare — Restructuring costs
$1.2M-62.5%
Bio-Rad Laboratories logo
BIOLife Science — Goodwill
$490.5M+47.2%
STERIS logo
STELife Sciences: — Cost of Revenue
$65.6M+7.7%
Ashland logo
ASHLife Sciences — Cost Of Revenue
$106M+2.9%
VAT
VATELife Sciences — Cost of revenue
$1.4M-39.1%
Bio-Rad Laboratories logo
BIOLife Science — Cost of goods sold
$100.9M+0.7%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×
P/S+4.7×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept ptct:OccupancyCosts.

The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001070081-26-000012
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Employee costs76,12167,699
Manufacturing costs9,08514,950
Administrative costs16,68818,414
Occupancy costs8,3547,183
Other segment items (a)107,889145,423
Segment net (loss) income$(2,809)$866,562
Reconciliation of profit or loss
Adjustments and reconciling items

Item 1. Financial Statements (unaudited)

FAQ

What is PTC Therapeutics's business segments — occupancy costs?
PTC Therapeutics (PTCT) reported business segments — occupancy costs of $8.35M in Q1 2026.
How has PTC Therapeutics's business segments — occupancy costs changed year-over-year?
PTC Therapeutics's business segments — occupancy costs increased by 16.3% year-over-year, from $7.18M to $8.35M.
What is the long-term trend for PTC Therapeutics's business segments — occupancy costs?
Over 3 years (2022 to 2025), PTC Therapeutics's business segments — occupancy costs has grown at a -8.2% compound annual growth rate (CAGR), from $38.26M to $29.56M.
What does business segments — occupancy costs mean?
This metric tracks the expenses related to facilities, rent, utilities, and maintenance for the physical infrastructure used by the life science segment. It reflects the fixed cost footprint required to house research laboratories and administrative offices.

Ask your AI about PTC Therapeutics's business segments — occupancy costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude